GlassScriptPhysician profile
Tom Liu
NPI 1760010953
$1,151.21
in general payments reported to CMS, 2019-2025
8 companies · $725 in 2025
The $725 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $427 · 2025: $725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,151.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $239.77 | 2024-2025 | Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Edwards Lifesciences Corporation | $188.93 | 2025 | |
| Medtronic, INC. | $182.03 | 2024-2025 | Corevalve Evolut R, Trillium Affinity Nt, Vitalflow Console |
| Davol INC. | $174.28 | 2025 | Arista |
| Acera Surgical, INC. | $127.18 | 2025 | Restrata Wound Matrix |
| W. L. Gore & Associates, INC. | $100.83 | 2025 | Gore Synecor Preperitoneal Biomaterial |
| Baxter Healthcare | $96.81 | 2024 | |
| Lemaitre Vascular, INC. | $41.38 | 2025 | Restoreflow |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tom Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.